Apolipoprotein B particles and cardiovascular disease: a narrative review

AD Sniderman, G Thanassoulis, T Glavinovic… - JAMA …, 2019 - jamanetwork.com
Importance The conventional model of atherosclerosis presumes that the mass of
cholesterol within very low-density lipoprotein particles, low-density lipoprotein particles …

Diabetes and atherosclerosis: epidemiology, pathophysiology, and management

JA Beckman, MA Creager, P Libby - Jama, 2002 - jamanetwork.com
ContextComplications of atherosclerosis cause most morbidity and mortality in patients with
diabetes mellitus. Despite the frequency and severity of disease, proven medical therapy …

[KNJIGA][B] Braunwald's heart disease e-book: A textbook of cardiovascular medicine

RO Bonow, DL Mann, DP Zipes, P Libby - 2011 - books.google.com
Braunwald's Heart Disease remains your indispensable source for definitive, state-of-the-art
answers on every aspect of contemporary cardiology. Edited by Drs. Robert O. Bonow …

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels

FM Sacks, MA Pfeffer, LA Moye… - … England Journal of …, 1996 - Mass Medical Soc
Background In patients with high cholesterol levels, lowering the cholesterol level reduces
the risk of coronary events, but the effect of lowering cholesterol levels in the majority of …

The mechanisms of action of PPARs

J Berger, DE Moller - Annual review of medicine, 2002 - annualreviews.org
▪ Abstract The peroxisome proliferator-activated receptors (PPARs) are a group of three
nuclear receptor isoforms, PPARγ, PPARα, and PPARδ, encoded by different genes. PPARs …

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol

HB Rubins, SJ Robins, D Collins, CL Fye… - … England Journal of …, 1999 - Mass Medical Soc
Background Although it is generally accepted that lowering elevated serum levels of low-
density lipoprotein (LDL) cholesterol in patients with coronary heart disease is beneficial …

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

Long-Term Intervention with Pravastatin in … - … England Journal of …, 1998 - Mass Medical Soc
Background In patients with coronary heart disease and a broad range of cholesterol levels,
cholesterol-lowering therapy reduces the risk of coronary events, but the effects on mortality …

Major risk factors as antecedents of fatal and nonfatal coronary heart disease events

P Greenland, MD Knoll, J Stamler, JD Neaton, AR Dyer… - Jama, 2003 - jamanetwork.com
ContextA frequently cited concept is that individual major risk factors for coronary heart
disease (CHD) are absent in many patients (perhaps> 50%) with CHD. However, prior …

High-density lipoproteins: a consensus statement from the National Lipid Association

PP Toth, PJ Barter, RS Rosenson, WE Boden… - Journal of clinical …, 2013 - Elsevier
For> 4 decades it has been recognized that elevated serum levels of high-density
lipoprotein cholesterol (HDL-C) are associated with reduced risk of cardiovascular disease …

Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial

SJ Robins, D Collins, JT Wittes, V Papademetriou… - Jama, 2001 - jamanetwork.com
ContextA low plasma level of high-density lipoprotein cholesterol (HDL-C) is a major risk
factor for coronary heart disease (CHD). A secondary prevention study, the Veterans Affairs …